Market Cap 1.59B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 7,176,410
Avg Vol 5,947,018
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 85%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
the_collective2
the_collective2 May. 26 at 6:01 PM
$ABCL options volume picking up on the 6/18 Starting to get eyes - I’d say we are near squeeze whatch territory
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 26 at 5:42 PM
$ABCL $ABCL - I don’t care much about technicals, but this is an uncommon setup so figure it is worth sharing. I think the shorts are in a very difficult position. Short interest at 21%, days to cover at 5 days, and a large spike in cost to borrow shares. The volume has been unusually strong as well. This thing is an insanely coiled spring - if the Phase 2 data is good this is going vertical.
1 · Reply
Plutten1973
Plutten1973 May. 26 at 5:37 PM
$ABCL feels more and more like the bomb will soon exploded im sure about that the shorters fight harder and harder and they pay more and more for that fight ,but but but sooner or later we all know they will loose everything is only about be patience for us that have been here forever
0 · Reply
Instwr
Instwr May. 26 at 4:51 PM
$ABCL 40% up since! Let’s push ⬆️
0 · Reply
the_collective2
the_collective2 May. 26 at 3:49 PM
$ABCL crazy buy order came in to send it right back up to 5.40 from 5.30. Being very careful here but just entered a significant call strategy. Own about 12k shares but this is clearly up to sow bring so options it is for me Good luck to all
0 · Reply
ispy
ispy May. 26 at 3:37 PM
$ABCL might start getting hyped from the ebola trend craze spooling up
0 · Reply
Druids
Druids May. 26 at 3:24 PM
$ABCL serious question. Who are the two most knowledgeable people on this forum about this company? I have shares and have traded this successfully or more truthfully, with good fortune, over the last few years. Im holding 21k shares and looking to follow a couple of people who know their stuff about it.
2 · Reply
bonecrack_benny
bonecrack_benny May. 26 at 2:36 PM
$ABCL going north
0 · Reply
the_collective2
the_collective2 May. 26 at 2:17 PM
$ABCL shocked this isn’t trending yet
0 · Reply
the_collective2
the_collective2 May. 26 at 2:16 PM
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 14 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 14 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 21 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 27 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 27 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 6 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


the_collective2
the_collective2 May. 26 at 6:01 PM
$ABCL options volume picking up on the 6/18 Starting to get eyes - I’d say we are near squeeze whatch territory
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 26 at 5:42 PM
$ABCL $ABCL - I don’t care much about technicals, but this is an uncommon setup so figure it is worth sharing. I think the shorts are in a very difficult position. Short interest at 21%, days to cover at 5 days, and a large spike in cost to borrow shares. The volume has been unusually strong as well. This thing is an insanely coiled spring - if the Phase 2 data is good this is going vertical.
1 · Reply
Plutten1973
Plutten1973 May. 26 at 5:37 PM
$ABCL feels more and more like the bomb will soon exploded im sure about that the shorters fight harder and harder and they pay more and more for that fight ,but but but sooner or later we all know they will loose everything is only about be patience for us that have been here forever
0 · Reply
Instwr
Instwr May. 26 at 4:51 PM
$ABCL 40% up since! Let’s push ⬆️
0 · Reply
the_collective2
the_collective2 May. 26 at 3:49 PM
$ABCL crazy buy order came in to send it right back up to 5.40 from 5.30. Being very careful here but just entered a significant call strategy. Own about 12k shares but this is clearly up to sow bring so options it is for me Good luck to all
0 · Reply
ispy
ispy May. 26 at 3:37 PM
$ABCL might start getting hyped from the ebola trend craze spooling up
0 · Reply
Druids
Druids May. 26 at 3:24 PM
$ABCL serious question. Who are the two most knowledgeable people on this forum about this company? I have shares and have traded this successfully or more truthfully, with good fortune, over the last few years. Im holding 21k shares and looking to follow a couple of people who know their stuff about it.
2 · Reply
bonecrack_benny
bonecrack_benny May. 26 at 2:36 PM
$ABCL going north
0 · Reply
the_collective2
the_collective2 May. 26 at 2:17 PM
$ABCL shocked this isn’t trending yet
0 · Reply
the_collective2
the_collective2 May. 26 at 2:16 PM
0 · Reply
Stockingtrade
Stockingtrade May. 26 at 2:02 PM
$ABCL Borrow rate at 15.01! Available shares to short dropped down precipitously, too. And price has gone up. Squeeeeeze!!!
1 · Reply
tradersunion353
tradersunion353 May. 26 at 1:50 PM
$ABCL knowing that fact that POS will drop after phase 2 data. Clowns who are married to stock are getting exciting like never before. Anything below $10 is POS performance for this stock Longs had enough we need to see the returns.
1 · Reply
8008track
8008track May. 26 at 1:36 PM
$ABCL if we are very lucky, we will get a flash crash on no news to $4 so that I can buy a lot more along with a few of my friends.
0 · Reply
bonecrack_benny
bonecrack_benny May. 26 at 12:56 PM
0 · Reply
tradersunion353
tradersunion353 May. 26 at 12:48 PM
$ABCL 5 years overhyped junk is down by 83% down by 30% on phase 1 data expecting phase 2 irrespetive of outcome stock wont make move then what are these married to ABCL clowns celebrating for??
1 · Reply
Ckkung71
Ckkung71 May. 26 at 12:45 PM
$ABCL Today it will be interesting if they try ⤵️ or if they have run out of power..
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 26 at 3:42 AM
$ABCL RSI: 58.50, MACD: 0.2179 Vol: 0.45, MA20: 4.58, MA50: 3.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
snowPOW
snowPOW May. 25 at 11:20 PM
$ABCL Good stuff here.
0 · Reply
tradersunion353
tradersunion353 May. 25 at 10:34 PM
$ABCL lots of fake longs overhyped junk without delivery any real value for real investors..
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:28 PM
$ABCL I have $ABCL fomo and I’m afraid it just gaps up hard this week and none of you get an entry. Might add pre market tonight.
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:11 PM
$ABCL Destined for greatness. Look at that volume…
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 6:23 PM
$ABCL Went from 9.5% to 14.79% this morning. It’s getting into painful territory for shorts, and if the price keeps going up, the 44m+ short interest (on a shrinking float, if institutions are taking positions) are going to be in real trouble. Very interesting!
0 · Reply